XML 41 R27.htm IDEA: XBRL DOCUMENT v3.19.2
Share-Based Payment Awards (Tables)
6 Months Ended
Jun. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Option Activity Under Plan

The following table provides a reconciliation of stock option activity under the Company’s equity incentive plans and for inducement awards for the six months ended June 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

of Options

 

 

Price

 

 

Life

 

 

Value

 

 

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding at January 1, 2019

 

 

8,139,377

 

 

$

2.83

 

 

 

 

 

 

 

 

 

Granted

 

 

4,162,096

 

 

 

2.43

 

 

 

 

 

 

 

 

 

Exercised

 

 

(166,760

)

 

 

1.84

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(555,474

)

 

 

2.55

 

 

 

 

 

 

 

 

 

Expired

 

 

(32,100

)

 

 

2.26

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2019

 

 

11,547,139

 

 

$

2.72

 

 

 

7.68

 

 

$

89

 

Exercisable at June 30, 2019

 

 

4,398,395

 

 

$

3.18

 

 

 

5.33

 

 

$

9

 

Schedule of Key Assumptions Used

In determining the grant date fair value of option awards during the six months ended June 30, 2019, the Company applied the Black-Scholes option pricing model based on the following key assumptions:

 

Option life (in years)

 

5.50 - 6.08

 

Stock volatility

 

60% - 64%

 

Risk-free interest rate

 

1.76% - 2.63%

 

Expected dividends

 

0.0%

 

Summary of Information about Stock Options

The following table summarizes information about employee, non-executive director and external consultant stock options for the six months ended June 30, 2019 (in thousands, except per share amount):

 

 

 

Six Months

Ended

 

 

 

June 30, 2019

 

Weighted-average grant date fair value per share

 

$

0.96

 

Total cash received from exercise of stock options

 

 

308

 

Total intrinsic value of stock options exercised

 

 

63

 

Summary of Restricted Stock Unit Activity

The following table provides a reconciliation of RSU activity under the 2016 Plan for the six months ended June 30, 2019:

 

 

 

 

 

 

 

Weighted

 

 

 

Number of

 

 

Average

 

 

 

Restricted

 

 

Grant Date

 

 

 

Stock Units

 

 

Fair Value

 

Nonvested at January 1, 2019

 

 

590,213

 

 

$

1.86

 

Granted

 

 

587,761

 

 

 

1.90

 

Vested

 

 

(206,067

)

 

 

1.79

 

Forfeited

 

 

(102,845

)

 

 

2.19

 

Nonvested at June 30, 2019

 

 

869,062

 

 

$

1.86

 

Summary of Performance Stock Unit Activity

The following table provides a reconciliation of PSU activity for the six months ended June 30, 2019:

 

 

 

 

 

 

 

Weighted

 

 

 

Number of

 

 

Average

 

 

 

Performance

 

 

Grant Date

 

 

 

Stock Units

 

 

Fair Value

 

Nonvested at January 1, 2019

 

 

370,000

 

 

$

2.01

 

Vested

 

 

(48,334

)

 

 

1.52

 

Forfeited

 

 

(20,000

)

 

 

1.77

 

Nonvested at June 30, 2019

 

 

301,666

 

 

$

2.10

 

Summary of Deferred Stock Unit Activity

 

 

 

 

 

 

Weighted

 

 

 

Number of

 

 

Average

 

 

 

Deferred

 

 

Grant Date

 

 

 

Stock Units

 

 

Fair Value

 

Nonvested at January 1, 2019

 

 

35,418

 

 

$

1.95

 

Vested

 

 

(35,001

)

 

 

1.95

 

Nonvested at June 30, 2019

 

 

417

 

 

$

2.32

 

 

Compensation Expense from Stock-Based Payment Awards

The Company’s consolidated statements of comprehensive loss included total compensation expense from stock-based payment awards for the three and six months ended June 30, 2019 and 2018, respectively, as follows (in thousands):

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Compensation expense included in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

268

 

 

$

345

 

 

$

664

 

 

$

660

 

Sales and marketing

 

 

179

 

 

 

50

 

 

 

323

 

 

 

50

 

General and administrative

 

 

1,049

 

 

 

579

 

 

 

1,747

 

 

 

707

 

 

 

$

1,496

 

 

$

974

 

 

$

2,734

 

 

$

1,417